MassDevice.com +5 | The top 5 medtech stories for June 22, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. J&J investor relations veep Mehrotra retires, Wolk steps up Johnson & Johnson said today its 10-year vice president of investor relations Louise Mehrotra will retire, effective January 2017, to be replaced by Joseph Wolk, effective August 1. Wolk previously served as vice president of group finance for Johnson & Johnson’s pharmaceuticals deivision, and has held other finance leadership positions prior to that, the company said. Read more 4. Five-year TAVR data reassure on durability Five-year data from a clinical trial of early transcatheter aortic valve replacements showed good durability, allaying concerns raised by a study last month in which more than a third of the valves deteriorated significantly over that span. Results from the Partner clinical trial, presented last week at the Transcatheter Valve Therapies conference in Chicago, showed a much lower mean gradient (the change in pressure across the valve) than were found in a smaller study presented in May at the annual EuroPCR meeting in Paris. The researchers behind that study predicted that as many ...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news